Latest From Biotech Now

Young Invincibles Still Need Flu Shot

Patient

Last Friday, the CDC reported that 35 states are seeing widespread cases of influenza. Young and middle aged adults are getting hit harder than usual this season due to the prevalence of the H1N1 (swine flu) strain, according to the Pittsburgh Post-Gazette. Most years, it’s the very young and very old who are most affected. Unlike 2009, when H1N1 re-emerged after lying dormant for decades, this year’s flu shot does include protection against H1N1. However, Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

What’s In Store for Biotechs at this Year’s CEO & Investor Conference

CEO2014_blog copy

In just a few weeks, industry leaders will gather in New York for one of BIO’s largest and most successful events, the 16th Annual BIO CEO & Investor Conference. As we’ve seen at JPMorgan, the extraordinary performance of biotech equities for the past several years has generated a great deal of interest among investors to work with biotech companies to foster innovation in the coming year. This year’s event is shaping up to be even Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

Congress Passes Omnibus Spending Agreement

Jim Greenwood

This week, BIO President and CEO Jim Greenwood praised the Congress for passing the fundingbill for fiscal 2014, which would, among other things, allow the Food and Drug Administration (FDA) to access $85 million in user fees sequestered in 2013. In addition, BIO supports the agreement’s overall funding for: FDA, NIH, the biodefense enterprise; and improved program oversight of the important 340B program.  BIO also strongly supports the language in the bill providing the Department Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Bioscience’s Bright Spots

2014_BIO

According to Business Xpansion Journal, biotech is still big business and partnerships lead to profit. And BIO agrees. “In the past several years, it has become more important than ever for those in our industry to form partnerships and collaborations,” says Fritz Bittenbender, executive vice president, external affairs, BIO. “Big pharma, small biotechs, universities, investors, patient groups, the NIH – everyone is recognizing that success is only achieved by working with others. One place we’ve seen this Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

GMO Opposition Creates Uncertainty for Farmers!

Cathleen_Enright copy

Dr. Cathleen Enright, BIO’s Executive Vice President for Food and Agriculture, recently presented at the American Farm Bureau Federation’s 2014 Annual Convention in San Antonio. On Sunday, January 13th, Dr. Enright briefed the group on issues and challenges confronting the agricultural biotechnology sector at her workshop titled, “Ensuring Our Access to Biotechnology.” Christopher Doering of the Des Moines Register wrote a wonderful piece capturing the essence of her talk. In his blog titled, Opposition to Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , ,